Carbenoxolone inhibits TRPV4 channel‐initiated oxidative urothelial injury and ameliorates cyclophosphamide‐induced bladder dysfunction

Carbenoxolone (CBX) is a clinically prescribed drug for the treatment of digestive ulcer and inflammation. It is also a widely used pharmacological inhibitor of several channels in basic research. Given that the overactivity of several channels, including those inhibitable by CBX, underlies bladder...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiling, Gao, Shan, Tanaka, Masayoshi, Zhang, Zhen, Huang, Yanru, Mitsui, Takahiko, Kamiyama, Manabu, Koizumi, Schuichi, Fan, Jianglin, Takeda, Masayuki, Yao, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571544/
https://www.ncbi.nlm.nih.gov/pubmed/28244642
http://dx.doi.org/10.1111/jcmm.13100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571544/
https://www.ncbi.nlm.nih.gov/pubmed/28244642
http://dx.doi.org/10.1111/jcmm.13100

Ejemplares similares